Kensington Investment Counsel’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,904
Closed -$509K 103
2023
Q2
$509K Sell
6,904
-372
-5% -$25.1K 0.32% 82
2023
Q1
$427K Sell
7,276
-3,161
-30% -$174K 0.32% 75
2022
Q4
$526K Sell
10,437
-2,659
-20% -$160K 0.41% 70
2022
Q3
$1.14M Buy
13,096
+597
+5% +$62.7K 0.96% 49
2022
Q2
$1.42M Sell
12,499
-206
-2% -$23.6K 1.21% 38
2022
Q1
$1.65M Sell
12,705
-1,361
-10% -$196K 1.09% 41
2021
Q4
$2.54M Buy
+14,066
New +$2.44M 1.48% 20
2021
Q2
$1.86M Buy
12,293
+307
+3% +$42.7K 1.28% 31
2021
Q1
$1.56M Buy
11,986
+1,023
+9% +$131K 1.17% 38
2020
Q4
$1.32M Buy
+10,963
New +$1.08M 1.09% 40

Other funds holding OMCL

Kensington Investment Counsel's OMCL Position: Q3 2023 in Review

Kensington Investment Counsel sold out of Omnicell (OMCL) in Q3 2023, closing a stake of 6,904 shares — an estimated $509K sold.

Kensington Investment Counsel first reported a position in OMCL in Q4 2020 and held it in 10 quarters. The position peaked at $2.54M in Q4 2021. 312 funds tracked by Wall St. Rank hold OMCL as of Q3 2023.

  • Kensington Investment Counsel reported no remaining Omnicell position as of Q3 2023 after selling out during the quarter.
  • Kensington Investment Counsel sold 6,904 Omnicell shares in Q3 2023, an estimated $509K.
  • Kensington Investment Counsel first reported a position in Omnicell in Q4 2020 and held it in 10 quarters.
  • Kensington Investment Counsel's Omnicell position peaked at $2.54M in Q4 2021.
  • 312 funds tracked by Wall St. Rank held Omnicell as of Q3 2023.

Based on Kensington Investment Counsel's 13F filing for Q3 2023, filed 9 Nov 2023.